| Tegafur studied in …STUDIED_INderived38 of 38show fewer |
|---|
| → studied in | NCT06339619Phase 2 · recruiting Combination Immunotherapy of Adebrelimab With Apatinib and Tegafur, Gimeracil and Oteracil Potassium Capsules for Immune Rechallenge Therapy in Esophageal Squamous Cell Carcinoma · 38 trials list this drug (8 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03406299Phase 2 · completed Phase II Randomized Trial of SLOG vs GC in Locally Advanced or Metastatic Biliary Tract Cancer · 38 trials list this drug (8 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06461910Phase 2 · recruiting Efficacy and Safety of Anti-PD-1, Thymalfasin, and SOX in Neoadjuvant Treatment of cStage III Gastric/Gastroesophageal Junction Adenocarcinoma · 38 trials list this drug (8 active) | — | — | Malignant Gastric Neoplasm,Gastroesophageal Junction Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07165847Phase 2 · recruiting Neoadjuvant Radiotherapy Plus Tegafur, Oxaliplatin and Iparomlimab and Tuvonralimab in Resectable Gastric and GE-junction Cancer : A Randomized, Two-arm, Prospective Trial (TRIUNITE-05) · 38 trials list this drug (8 active) | — | — | Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06988956Phase 2 · recruiting Nimotuzumab Plus Definite Chemoradiotherapy(dCRT) in Elderly Patients With Esophageal Squamous Cell Carcinoma · 38 trials list this drug (8 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05223088Phase 2 · completed Tislelizumab Combined With Apatinib and Oxaliplatin Plus S1 as Neoadjuvant Therapy for Borrmann IV、Large Borrmann III Type and Bulky N Positive Advanced Gastric Cancer · 38 trials list this drug (8 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03175679Phase 1 · completed Adoptive Transfer of iNKT Cells for Treating Patients With Relapsed/Advanced HCC · 38 trials list this drug (8 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06603974NA · not yet recruiting The Efficacy and Safety of Benmelstobart for GC/EGC · 38 trials list this drug (8 active) | — | — | Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06354140Phase 2 · recruiting PPIO-008 Tislelizumab Combined With S-1 in Patients With ypT+N0 ESCC After Radical Resection With Neoadjuvant STUDY · 38 trials list this drug (8 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06383078Phase 2 · not yet recruiting HR070803 in Combination With Oxaliplatin, S-1 Versus NALIRIFOX as Adjuvant Therapy for Pancreatic Cancer · 38 trials list this drug (8 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05914610Phase 3 · not yet recruiting Envollizumab Combined With Fruquintinib and SOX Versus SOX for Conversion Therapy in Advanced Gastric Cancer · 38 trials list this drug (8 active) | — | — | Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004860Phase 2 · completed Fluorouracil-Uracil and Leucovorin in Treating Elderly Patients With Metastatic Colorectal Cancer · 38 trials list this drug (8 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01845337Phase 2 · completed Study to Compare Cardiovascular Side Effects of Teysuno Versus Capecitabine · 38 trials list this drug (8 active) | — | — | Malignant Digestive System Neoplasm,Bile Duct Neoplasm,Malignant Neoplasm of Unknown Primary+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05817201Phase 2/Phase 3 · unknown Toripalimab Plus Radiotherapy for Elderly Esophageal Cancer Patients Treated With Non-chemotherapy Strategy · 38 trials list this drug (8 active) | — | — | Malignant Esophageal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05396326Phase 1 · unknown A Pilot Study of Neoadjuvant TACiE in Locally Advanced Gastric Cancer · 38 trials list this drug (8 active) | — | — | Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05346874Phase 2 · unknown Neoadjuvant TACiE in Locally Advanced Gastric Cancer · 38 trials list this drug (8 active) | — | — | Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04216758Phase 2 · unknown Nab-P and Gem Compared With Gem and Tegafur in Adjuvant Chemotherapy After Radical Resection of Pancreatic Cancer · 38 trials list this drug (8 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04135781Phase 3 · unknown Nab-paclitaxel Combined With S-1 as Adjuvant Chemotherapy for Stage Ⅲ Gastric Cancer · 38 trials list this drug (8 active) | — | — | Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03121313Phase 2 · unknown Maintenance Tegafur-uracil in Resected Oral Cavity Cancer With ECS+ · 38 trials list this drug (8 active) | — | — | Oral Cavity Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03702491Phase 2 · unknown Apapitatin Combined With SOX for Palliative Adjuvant Chemotherapy in Patients With Advanced Gallbladder Carcinoma · 38 trials list this drug (8 active) | — | — | Gallbladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01918852Phase 3 · completed S-1 Versus Capecitabine in the First Line Treatment of MCC Patients. · 38 trials list this drug (8 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03175705Phase 1 · unknown Adoptive Transfer of Specific HCC Antigens CD8+ T Cells for Treating Patients With Relapsed/Advanced HCC · 38 trials list this drug (8 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03204032Phase 2 · unknown A Study of Tegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Subjects With Advanced Extrapancreatic Neuroendocrine Tumor · 38 trials list this drug (8 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02836977NA · unknown Maintenance Tegafur-uracil Versus Observation Following Adjuvant Oxaliplatin-based Regimen in Patients With Stage III Colon Cancer After Radical Resection · 38 trials list this drug (8 active) | — | — | Malignant Colon Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02447679Phase 2 · completed Oral Thalidomide and Tegafur-uracil to Decrease Hepatocellular Carcinoma Recurrence · 38 trials list this drug (8 active) | — | — | Hepatocellular Carcinoma,Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02887365Phase 4 · unknown A Phase II Study of Tegafur-Uracil as Maintenance Chemotherapy in Patients With Stage II of Colon Cancer · 38 trials list this drug (8 active) | — | — | Malignant Colon Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00660894Phase 3 · completed Tegafur-Uracil and Leucovorin or S-1 in Treating Patients With Stage III Colon Cancer That Has Been Completely Removed by Surgery · 38 trials list this drug (8 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002801Phase 1 · completed Combination Chemotherapy and Radiation Therapy in Treating Patients With Colorectal Cancer · 38 trials list this drug (8 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00009815Phase 1 · withdrawn Combination Chemotherapy in Treating Patients With Advanced Solid Tumors · 38 trials list this drug (8 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00009828Phase 1 · withdrawn Paclitaxel Combined With Fluorouracil-Uracil and Leucovorin in Treating Patients With Solid Tumors · 38 trials list this drug (8 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00336947Phase 3 · unknown S-1 or Tegafur-Uracil in Treating Patients With Previously Treated Stage III or Stage IV Head and Neck Cancer · 38 trials list this drug (8 active) | — | — | Malignant Head and Neck Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003925Phase 1 · completed Combination Chemotherapy In Treating Patients With Advanced Cancer · 38 trials list this drug (8 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00385970Phase 3 · unknown A Phase III Trial Comparing UFT+PSK to UFT+LV in Stage IIB, III Colorectal Cancer · 38 trials list this drug (8 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005608Phase 2 · terminated Fluorouracil-Uracil and Leucovorin in Treating Women With Metastatic Breast Cancer · 38 trials list this drug (8 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00519688Phase 2 · completed UFUR Plus Thalidomide for Advanced Hepatocellular Carcinoma · 38 trials list this drug (8 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00855881Phase 2 · unknown Metronomic Chemotherapy With Tegafur/Uracil for Head and Neck Squamous Cell Carcinoma · 38 trials list this drug (8 active) | — | — | Malignant Head and Neck Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00378716Phase 3 · completed Combination Chemotherapy in Treating Patients With Resected Colon Cancer · 38 trials list this drug (8 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00464919Phase 2 · completed Sorafenib Plus Tegafur/Uracil (UFUR®) for Hepatocellular Carcinoma (HCC) · 38 trials list this drug (8 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |